Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers

Biosearch Life

Status: Unknown

Conditions: Covid-19

Treatments: Dietary Supplement: Control; Dietary Supplement: Probiotic

Study type: Interventional

Funder types: Industry

Identifiers

NCT04366180

P054

Details and patient eligibility

About

The aim of the present study is to evaluate the effects of Lactobacillus coryniformis K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study

Enrollment: 314 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Persons over 20 years of age.
2. Active healthcare personnel, who attend patients with COVID-19 disease, including all professional categories, medicine, nursing and warders.
3. Ability to complete surveys.
4. Signature of informed consent

Exclusion criteria

1. Person with positive test of COVID-19 confirmed by PCR test or serology
2. Person with concomitant pathology HIV, transplant, active oncology or other type of active immunosuppression
3. Pregnant women or women with intention to become pregnant in the next 2 months.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

314 participants in 2 patient groups, including a placebo group

Probiotic

Experimental group

Description:

Experimental group who will receive one capsule of Lactobacillus K8 per day (3x10\^9 cfu/day).

Treatment:

Dietary Supplement: Probiotic

Control

Placebo Comparator group

Description:

Control group who will receive a daily placebo capsule consisting of maltodextrin

Treatment:

Dietary Supplement: Control